Pharmafile Logo
Pharmafocus logo
Advanced Search
imbruvica_logo_0

NICE approves Imbruvica for second-line leukaemia treatment

January 26, 2017
Medical Communications, Sales and Marketing AbbVie, CLL, Janssen, ibrutinib, imbruvica

NICE has issued its Technology Appraisal Guidance (TAG) that has recommend Imbruvica (ibrutinib) for the treatment of chronic lymphocytic leukaemia …

News
leukamia

Two infants in remission from leukaemia after CAR T-Cell therapy

January 26, 2017
Research and Development

Researchers at the Great Ormond Street Hospital have published the successful treatment of two infants suffering from leukaemia by treatment …

News
currency-166422_960_720

India’s NPPA slashes essential drug prices by up to 50%

January 26, 2017
Sales and Marketing India, nppa, pricing

India’s governmental regulatory agency, the National Pharmaceutical Pricing Authority (NPPA), has addressed the pricing of 33 medicines including antibiotics and …

News
pharma_pill_manufacturing

Jazz Pharmaceuticals UK supplier hit with FDA warning

January 26, 2017
Manufacturing and Production Erwinaze, Porton Biopharma, jazz pharmaceuticals

UK-based Porton Biopharma, supplier of Irish company Jazz Pharmaceuticals’ leukaemia treatment Erwinaze, has been slapped with an FDA warning letter …

News
jj

J&J finally seals $30 billion deal for Actelion

January 26, 2017
Sales and Marketing Actelion, Janssen, Johnson & Johnson

Johnson & Johnson has, as expected, wrapped up the deal to acquire Actelion in a deal worth $30 billion, working …

News
regeneron

Regeneron agrees ownership of HQ for $720m after 25 years

January 25, 2017
Manufacturing and Production, Medical Communications Regeneron

After leasing the property for 25 years, Regeneron has agreed to take ownership of its headquarters and buy the Landmark …

News

Hospira in US-wide recall of product due to contamination

January 25, 2017
Medical Communications Contamination, Hospira, Pfizer

Hospira, a company owned by Pfizer, has been forced to recall a batch of injectable drugs due to “the presence …

News
peter_wheatley_price

Takeda UK names new market access director

January 25, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda

Takeda UK has appointed Peter Wheatley Price to the role of market access director, where he will also sit on …

Appointment

MHRA accepts Roche’s Tecentriq into Early Access to Medicines scheme

January 25, 2017
Research and Development, Sales and Marketing MHRA, Roche, eams, tecentriq

Roche’s Tecentriq (atezolizumab) has scored another positive opinion, this time from the Medicines and Healthcare products Regulatory Agency (MHRA), which …

News
medication

Statins revealed to potentially aid cancer treatment

January 25, 2017
Research and Development Cancer, University of Kansan, statins

New research, conducted at the University of Kansas, has emerged that reveal a potential use for statins beyond their current …

News
shutterstock_187433765

Two-step treatment cuts off cancer’s backup defences

January 25, 2017
Research and Development Cancer, sarcoma, washington university

New research conducted at Washington University’s School of Medicine and published in Cell Reports details a new method for fighting …

News
cancer_cells

Breakthrough treatment for pancreatic cancer doubles survival rates

January 25, 2017
Research and Development CRUK, Cancer Research UK, Pancreatic cancer

Research led by Liverpool University and funded by Cancer Research UK has shown that a combination treatment of two off-patent …

News

Indian pharma firm caught shredding documents at 1am by FDA

January 24, 2017
Manufacturing and Production, Research and Development FDA, Hetero Labs, observations

Hetero Labs, an Indian pharmaceutical firm, has been observed by the FDA shredding what the FDA judged to be controlled …

News
pharmafocus_march

Pharmafocus January/February is now live!

January 24, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, digital edition

Inside this issue…

News
abbvie_0

EMA Accelerated Assessment for AbbVie’s hepatitis C regimen

January 24, 2017
Manufacturing and Production, Research and Development AbbVie, EMA, hepatitis C

AbbVie has announced that its investigational, pan-genotypic regimen of Glecaprevir/Pibrentasvir has been awarded Accelerated Assessment by the European Medicines Agency …

News
phrma_logo

US Pharma launches multi-million dollar media campaign to deflect pricing criticism

January 24, 2017
Manufacturing and Production, Medical Communications PhMRA, Trump

In response to a number of recent criticisms over pricing including president Trump’s message that pharma companies are “getting away …

News
roche_close

Roche’s Actemra granted Priority Review by FDA

January 24, 2017
Manufacturing and Production, Sales and Marketing Actemra, FDA, Roche, priority review

Roche’s drug, Actemra (also known as RoActemra in Europe), has been granted priority review designation by the FDA for the …

News
computer_doctor

Thinking big data

January 23, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Data, IBM Watson Health, ibm

The potential solutions offered by ‘big data’ seems to offer a vision of the future but potential solutions aren’t enough …

Feature
kaleo

Rival to EpiPen to be made available to many for free

January 23, 2017
Manufacturing and Production, Sales and Marketing Kaleo, Mylan, epipen, rival

Mylan has been under scrutiny over its pricing policy with its branded EpiPen; the pressure told and led to them …

News
vaccination-1215279_960_720

CEPI backed by Bill Gates raises funds to combat epidemics

January 23, 2017
Medical Communications, Sales and Marketing Bill & Melinda Gates foundation, Bill Gates, CEPI

CEPI, the Coalition for Epidemic Preparedness Innovations, have launched the beginning of its fundraising initiative – with the aim of …

News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026